Immune Infiltration in Tumor and Adjacent Non-Neoplastic Regions Codetermines Patient Clinical Outcomes in Early-Stage Lung Cancer is a research paper published in Journal of Thoracic Oncology (2023). On theSindex it has a DataRank of 0. It has been cited 45 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: 1R01CA269764
NCI NIH HHS
Grant: R35 CA197449
Cancer Prevention and Research Institute of Texas
Grant: RR170048
NCI NIH HHS
Grant: U01 CA209414
NCI NIH HHS
Grant: R01 CA269764
NCI NIH HHS
Grant: R21 CA227996
NCI NIH HHS
Grant: R03 CA262911
NCI NIH HHS
Grant: U19 CA203654
Cancer Prevention and Research Institute of Texas
Grant: RR180061
National Cancer Institute
FWCI
6.25
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Additional file 1 of Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Additional file 2 of Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Additional file 2 of Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Additional file 3 of Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Additional file 3 of Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Additional file 4 of Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Additional file 4 of Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Additional file 6 of Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Additional file 6 of Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Additional file 7 of Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Additional file 7 of Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Additional file 10 of Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Additional file 11 of Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Additional file 9 of Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Additional file 9 of Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Additional file 11 of Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Additional file 10 of Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Additional file 5 of Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer
Additional file 8 of Integrated profiling identifies DXS253E as a potential prognostic marker in colorectal cancer